IVD Raw Materials Market Size, Share & Trends Analysis Report By Product (Antibody, Antigens, Proteins, Enzymes, Biological Buffers, Substrates, Others), By Technology (Molecular Diagnostics, Clinical Chemistry, Immunochemistry, Others), By End User (Diagnostic Laboratories, Pharmaceutical & Biotechnological Companies, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: March 06, 2026 | Author: Mitiksha Koul | Format: | Report Code: SR5052DR | Pages: 160

Market Segmentation

  1. IVD Raw Materials Market, By Product 2022-2034 (USD MILLION/ Units)
    1. Antibody
    2. Antigens
    3. Proteins
    4. Enzymes
    5. Biological Buffers
    6. Substrates
    7. Others
  2. IVD Raw Materials Market, By Technology 2022-2034 (USD MILLION/ Units)
    1. Molecular Diagnostics
    2. Clinical Chemistry
    3. Immunochemistry
    4. Others
  3. IVD Raw Materials Market, By End User 2022-2034 (USD MILLION/ Units)
    1. Diagnostic Laboratories
    2. Pharmaceutical & Biotechnological Companies
    3. Others
  4. Regional IVD Raw Materials Market
    1. North America
      1. North America IVD Raw Materials Market By Product 2022-2034 (USD MILLION/ Units)
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
      2. North America IVD Raw Materials Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Molecular Diagnostics
        2. Clinical Chemistry
        3. Immunochemistry
        4. Others
      3. North America IVD Raw Materials Market By End User 2022-2034 (USD MILLION/ Units)
        1. Diagnostic Laboratories
        2. Pharmaceutical & Biotechnological Companies
        3. Others
      4. U.S.
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
      5. Canada
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
    2. Europe
      1. Europe IVD Raw Materials Market By Product 2022-2034 (USD MILLION/ Units)
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
      2. Europe IVD Raw Materials Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Molecular Diagnostics
        2. Clinical Chemistry
        3. Immunochemistry
        4. Others
      3. Europe IVD Raw Materials Market By End User 2022-2034 (USD MILLION/ Units)
        1. Diagnostic Laboratories
        2. Pharmaceutical & Biotechnological Companies
        3. Others
      4. U.K.
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
      5. Germany
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
      6. France
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
      7. Spain
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
      8. Italy
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
      9. Russia
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
      10. Nordic
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
      11. Benelux
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
      12. Rest of Europe
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
    3. APAC
      1. APAC IVD Raw Materials Market By Product 2022-2034 (USD MILLION/ Units)
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
      2. APAC IVD Raw Materials Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Molecular Diagnostics
        2. Clinical Chemistry
        3. Immunochemistry
        4. Others
      3. APAC IVD Raw Materials Market By End User 2022-2034 (USD MILLION/ Units)
        1. Diagnostic Laboratories
        2. Pharmaceutical & Biotechnological Companies
        3. Others
      4. China
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
      5. Korea
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
      6. Japan
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
      7. India
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
      8. Australia
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
      9. Singapore
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
      10. Taiwan
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
      11. South East Asia
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
      12. Rest of Asia-Pacific
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
    4. Middle East and Africa
      1. Middle East and Africa IVD Raw Materials Market By Product 2022-2034 (USD MILLION/ Units)
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
      2. Middle East and Africa IVD Raw Materials Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Molecular Diagnostics
        2. Clinical Chemistry
        3. Immunochemistry
        4. Others
      3. Middle East and Africa IVD Raw Materials Market By End User 2022-2034 (USD MILLION/ Units)
        1. Diagnostic Laboratories
        2. Pharmaceutical & Biotechnological Companies
        3. Others
      4. UAE
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
      5. Turkey
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
      6. Saudi Arabia
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
      7. South Africa
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
      8. Egypt
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
      9. Nigeria
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
      10. Rest of MEA
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
    5. LATAM
      1. LATAM IVD Raw Materials Market By Product 2022-2034 (USD MILLION/ Units)
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
      2. LATAM IVD Raw Materials Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Molecular Diagnostics
        2. Clinical Chemistry
        3. Immunochemistry
        4. Others
      3. LATAM IVD Raw Materials Market By End User 2022-2034 (USD MILLION/ Units)
        1. Diagnostic Laboratories
        2. Pharmaceutical & Biotechnological Companies
        3. Others
      4. Brazil
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
      5. Mexico
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
      6. Argentina
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
      7. Chile
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
      8. Colombia
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
      9. Rest of LATAM
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on: